Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are ComingAHA News: Are Monolingual Spanish Speakers More at Risk in the Pandemic?Your Free Cancer Screen Shows Trouble: What If You Can't Afford the Follow-Up?Bystanders Can Make the Difference for a Drowning ChildClimate Change is World's Most Pressing Health Problem: WHOAHA News: Another Barrier for Black and Hispanic People: Good Mental Health CareU.S. to Buy $1 Billion Worth of Rapid COVID TestsNearly 200,000 COVID Home Tests Recalled Over False PositivesMedical Mistrust Fuels Vaccine Hesitancy Among HispanicsAmericans Divided on Biden's Vaccine Mandate, Poll FindsAir Pollution Linked to 6 Million Premature Births in 1 YearDelay in Graphic Warning Labels on Cigarettes Cost Lives: StudyAHA News: Women May Be More Willing Than Men to Donate OrgansEPA to Sharply Limit Refrigerant Production in New Climate RuleAHA News: Food Insecurity's Long-Term Health ConsequencesU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationNIH Spending Nearly $470 Million on Long-Haul COVID StudyCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterFDA Bans Sale of Nearly a Million E-Cigarettes; Allows Juul to Remain on MarketMore Affordable Housing, Healthier Hearts?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanU.S. COVID Vaccination Rates Climb in AugustGreener Neighborhoods Bring Healthier Hearts, Study ShowsU.S. to Be Removed From E.U. Safe Travel ListFDA Tells Three Small E-Cigarette Makers to Stop Selling Flavored ProductsFratelli Beretta Antipasto Trays Are the Source of Salmonella Outbreak: CDCHow Your Medicines Make Their Way Into Rivers, Lakes and BaysFamily Behind Oxycontin Denies Any Responsibility for Opioid CrisisCommon Pesticide to Be Banned Over Links to  Problems in ChildrenFar Too Few People of Color in U.S. Pancreatic Cancer TrialsRace-Based Disparities in Americans' Health Haven't Improved: StudyChild Injuries, Deaths Spur Recall of 10 Million Magnet Balls, CubesAmericans Have High Trust in Health Care Providers: PollBreaded, Raw Chicken Recalled in Multi-State Salmonella OutbreakU.S. Military Members Must Get COVID Vaccine by Mid-September6 Tips on Getting Back to Your Regular Doctor's CheckupNursing Home Staff Closest to Patients Are Least Likely to Get COVID Vaccines
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

NIH Spending Nearly $470 Million on Long-Haul COVID Study

HealthDay News
by Steven Reinberg
Updated: Sep 16th 2021

new article illustration

THURSDAY, Sept. 16, 2021 (HealthDay News) -- The U.S. National Institutes of Health is spending nearly $470 million to study the long-term effects of COVID-19, the agency announced Wednesday.

NIH has awarded a "parent" grant to New York University (NYU) Langone Health, which will in turn make awards to more than 100 researchers at more than 30 institutions.

The goal is to uncover why some people have prolonged symptoms (long-haul COVID) or develop new or returning symptoms after recovering from COVID-19. The most common symptoms include pain, headaches, fatigue, "brain fog," shortness of breath, anxiety, depression, fever, chronic cough and sleep problems.

"We know some people have had their lives completely upended by the major long-term effects of COVID-19," NIH Director Dr. Francis Collins said.

"These studies will aim to determine the cause and find much needed answers to prevent this often-debilitating condition and help those who suffer move toward recovery," he said in an agency news release.

The program is called Researching COVID to Enhance Recovery (RECOVER). Data from RECOVER will include clinical information, laboratory tests and analyses of various stages of recovery following infection.

"This scientifically rigorous approach puts into place a collaborative and multidisciplinary research community inclusive of diverse research participants that are critical to informing the treatment and prevention of the long-term effects of COVID-19," said Dr. Gary Gibbons, director of NIH's National Heart, Lung, and Blood Institute.

These studies are expected to give insights into the incidence and prevalence of long-term effects from COVID-19, the range of symptoms, underlying causes, risk factors and outcomes.

Participants will include adults, children and pregnant people who are in the throes of COVID or recovering. Funding is supported by the American Rescue Plan.

"Given the range of symptoms that have been reported, intensive research using all available tools is necessary to understand what happens to stall recovery from this terrible virus," said Dr. Walter Koroshetz, director of NIH's National Institute of Neurological Disorders and Stroke. "Importantly, the tissue pathology studies in RECOVER will enable in-depth studies of the virus's effects on all body systems."

More information

For more on long-term COVID-19, see the U.S. Centers for Disease Control and Prevention.

SOURCE: U.S. National Institutes of Health, news release, Sept. 15, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net